On November 23, 2021, the California Institute for Regenerative Medicine (CIRM) governing board approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health to address disparities in cancer research, treatment and outcomes in underrepresented populations.